Infographic: Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial

Bone Joint J. 2021 Mar;103-B(3):440-441. doi: 10.1302/0301-620X.103B3.BJJ-2021-0172.

Authors

V S Nikolaou¹, P Masouros², T Floros¹, E Chronopoulos, M Skertsou³, G C Babis¹

Affiliations

¹ 2nd Academic Department of Orthopaedics, School of Medicine, Konstandopoulio General Hospital, National & Kapodistrian University of Athens, Athens, Greece.
² Department of Orthopaedic, Evangelismos General Hospital, Athens, Greece.
³ Department of Haematology, Konstandopoulio General Hospital, Athens, Greece.

PMID: 33641417
DOI: 10.1302/0301-620X.103B3.BJJ-2021-0172

No abstract available

Publication types

Randomized Controlled Trial

MeSH terms

Aged, 80 and over
Antifibrinolytic Agents
Arthroplasty, Replacement, Hip / adverse effects*
Blood Loss, Surgical / prevention & control*
Blood Transfusion / methods*
Data Visualization
Dose-Response Relationship, Drug
Female
Hip Fractures / surgery*
Humans
Male
Tranexamic Acid / administration & dosage*

Substances

Antifibrinolytic Agents
Tranexamic Acid